Uber-GrubHub Merger Will Devastate Restaurants, Harm Workers and Hurt Consumers
May 12, 2020 - The American Economic Liberties Project released the following statement in response to reporting from the Wall Street Journal, which revealed that Uber, the parent company of Uber Eats, is seeking to acquire GrubHub.
Economic Liberties Launches New Website and Welcomes Nine New Members to its Team
May 12, 2020 - The American Economic Liberties Project, which launched in February to advance a growing, cross-ideological movement to combat monopolies and the systems that entrench their power, today launched a new website and welcomed nine new members to its team: Pat Garafolo, Denise Hearn, Leah Hunt Hendrix, Laleh Ispahani, Nia Johnson, Robyn Shapiro, Maureen Tkacik, Lori Wallach, and Kate Yeager.
25+ National & State Orgs Urge Congress to Pass the Pandemic Anti-Monopoly Act
May 8, 2020 - As large corporations and predatory financiers seek to exploit the global pandemic and further concentrate their economic and political power, 27 national and state organizations today sent a letter to Speaker Nancy Pelosi and Minority Leader Chuck Schumer, urging them to include the Pandemic Anti-Monopoly Act in the next COVID-19 relief package.
The Federal Reserve Must Not Finance a Merger Wave
May 7, 2020 - With dominant corporations and predatory financiers strengthened by the CARES Act and better positioned to buy up businesses in distress, nine groups today sent a letter to Federal Reserve Chairman Jerome Powell and Treasury Secretary Steven Mnuchin urging them to freeze all mergers and acquisitions activity by otherwise viable corporations as a condition for use of the Federal Reserve and Treasury’s emergency credit programs.
AbbVie-Allergan Merger Will Raise Costs, Reduce Innovation, and Prolong Drug Shortages
May 6, 2020 - The American Economic Liberties Project released the following statement in response to the Federal Trade Commission’s (FTC) announcement yesterday that it recklessy approved pharmaceutical company AbbVie’s $63 billion acquisition of Allergan in a 3-2 vote with Commissioners Chopra and Slaughter dissenting.